📑"Levosimendan y otros (medicamentos)"
Procurement process summary
This process is to purchase "Levosimendan y otros (medicamentos)".
This contract was awarded by 🇺🇾 Dirección Nacional de Sanidad de las Fuerzas Armadas for an amount of UYU 52,058 to 1 supplier. It was published on 2014-02-13 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇺🇾 Dirección Nacional de Sanidad de las Fuerzas Armadas Buying unitnot reported Publication date2014-02-13 Contest statusnot reported DescriptionCompra Directa 498/2013Awards
This award was granted to ABBOTT LABORATORIES URUGUAY SA by Dirección Nacional de Sanidad de las Fuerzas Armadas for an amount of UYU 52,058. The procurement process was conducted through open for the category of Not available. The award was granted on 2014-02-11.
| Supplier | Amount | Award date |
|---|---|---|
| 🇺🇾 ABBOTT LABORATORIES URUGUAY SA | UYU 52,058 | 2014-02-11 |
Market context and opportunities
The execution of this contract allows the entity Dirección Nacional de Sanidad de las Fuerzas Armadas to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberUY_ocds-yfs5dr-398565-R-210133230015Publication date2014-02-13Contract datenot reportedAward date2014-02-11Categoriesnot reportedPurchase modalityopenMethod detailsCompra DirectaStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
